Matthias Schaefers

Summary

Affiliation: Bayer HealthCare AG
Country: Germany

Publications

  1. ncbi Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial
    Matthias Schaefers
    Bayer Schering Pharma AG, Berlin, Germany
    Menopause 16:559-65. 2009

Detail Information

Publications1

  1. ncbi Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial
    Matthias Schaefers
    Bayer Schering Pharma AG, Berlin, Germany
    Menopause 16:559-65. 2009
    ....